Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study-Reference-Cited by-同舟云学术

Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study

Published:2023-06-20 Issue: Volume: Page:1-19
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Rathod Sanket¹^ORCID,Dey Sreenath²^ORCID,Pawar Swaranjali¹^ORCID,Dhavale Rakesh³^ORCID,Choudhari Prafulla¹^ORCID,Rajakumara Eerappa²^ORCID,Mahuli Deepak⁴^ORCID,Bhagwat Durgacharan³^ORCID,Tamboli Yasinalli⁵^ORCID,Sankpal Poournima⁶^ORCID,Mali Sachin⁷^ORCID,More Harinath¹^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Bharati Vidyapeeth College of Pharmacy, Kolhapur, MS, India

2. Department of Biotechnology, Indian Institute of Technology, Hyderabad, Kandi, Sangareddy, Telangana, India

3. Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Kolhapur, MS, India

4. Department of Pharmacology, Bharati Vidyapeeth College of Pharmacy, Kolhapur, MS, India

5. King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia

6. Department of Pharmaceutical Chemistry, Ashokrao Mane College of Pharmacy, Kolhapur, MS, India

7. Department of Pharmaceutics, Y. D. Mane College of Pharmacy, Kagal, MS, India Kolhapur

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2023.2225099

Reference106 articles.

1. Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties

2. Terminators or Guardians? Design, Synthesis, and Cytotoxicity Profiling of Chalcone-Sulfonamide Hybrids

3. In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2